The STEEPLE trial randomised more than 3500 elective angioplasty patients to unfractionated heparin or either of two dose levels of enoxaparin. Gilles Montalescot presented the findings in Stockholm and talked about them with Audio Medica.
[audio:https://www.audiomedica.com/podcasting/15.Gilles_Montalescot-The_STEEPLE_trial_randomised_more_than_3500_elective_angioplasty_patients.mp3]
Could “Polypill” Massively Reduce Heart, Stroke Risks In Healthy People? 31 Mar, 2009 Drug-Free Blood Pressure Reduction By Catheter Nerve Ablation 2 Apr, 2009 
Direct infusions of HDL to prevent re-infarction in patients with acute coronary syndromes 16 Nov, 2012 
Important new role for aspirin: prevention of recurrent thromboembolism: ASPIRE findings 12 Nov, 2012 
Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014MMR vaccine’s non-specific effects: adherence to recommended vaccination schedules protects children against non-vaccination-specific infections tooFebruary 28, 2014